advanced from pre-clinical to phase II in the last 12 months
and two phase II trials will be active next year
cant complain
Ann: AGM - Chief Executive Officer's Presentatioin, page-2
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.59M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3694 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 09.22am 27/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |
Day chart unavailable